Literature DB >> 22052662

Electrocardiographic consequences of cardiac iron overload in thalassemia major.

Jon Detterich1, Leila Noetzli, Fred Dorey, Yaniv Bar-Cohen, Paul Harmatz, Thomas Coates, John Wood.   

Abstract

Iron cardiomyopathy is a leading cause of death in transfusion-dependent thalassemia major (TM) patients and MRI (T2*) can recognize preclinical cardiac iron overload, but, is unavailable to many centers. We evaluated the ability of 12-lead electrocardiography to predict cardiac iron loading in TM. 12-lead electrocardiogram and cardiac T2* measurements were performed prospectively, with a detectable cardiac iron cutoff of T2*less than 20 ms. Patients with and without cardiac iron were compared using two-sample statistics and against population norms using age and gender-matched Z-scores. 45/78 patients had detectable cardiac iron. Patients having cardiac iron were older and more likely female but had comparable liver iron burdens and serum ferritin. Increased heart rate (HR) and prolonged corrected QT interval (QT(c)) were present, regardless of cardiac iron status. Repolarization abnormalities were the strongest predictors of cardiac iron, including QT/QT(c) prolongation, left shift of T-wave axis, and interpretation of ST/T-wave morphology. Recursive partitioning of the data for females using T-axis and HR and for males using QT, HR, and T-axis produced algorithms with AUROC's of 88.3 and 87.1, respectively. Bradycardia and repolarization abnormalities on 12-lead electrocardiography were the most specific markers for cardiac iron in thalassemia major. Changes in these variables may be helpful to stratify cardiac risk when cardiac MRI is unavailable. However, diagnostic algorithms need to be vetted on larger and more diverse patient populations and longitudinal studies are necessary to determine reversibility of the observed abnormalities.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22052662      PMCID: PMC3306475          DOI: 10.1002/ajh.22205

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  40 in total

1.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors:  L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

2.  Revisiting the relationship between vitamin D deficiency, cardiac iron and cardiac function in thalassemia major.

Authors:  Leila J Noetzli; Susan Carson; Thomas D Coates; John C Wood
Journal:  Eur J Haematol       Date:  2010-12-22       Impact factor: 2.997

Review 3.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology.

Authors:  Pentti M Rautaharju; Borys Surawicz; Leonard S Gettes; James J Bailey; Rory Childers; Barbara J Deal; Anton Gorgels; E William Hancock; Mark Josephson; Paul Kligfield; Jan A Kors; Peter Macfarlane; Jay W Mason; David M Mirvis; Peter Okin; Olle Pahlm; Gerard van Herpen; Galen S Wagner; Hein Wellens
Journal:  Circulation       Date:  2009-02-19       Impact factor: 29.690

4.  Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron.

Authors:  Anna Ramazzotti; Alessia Pepe; Vincenzo Positano; Giuseppe Rossi; Daniele De Marchi; Maria Gabriella Brizi; Antongiulio Luciani; Massimo Midiri; Giuseppina Sallustio; Gianluca Valeri; Vincenzo Caruso; Michele Centra; Paolo Cianciulli; Vincenzo De Sanctis; Aurelio Maggio; Massimo Lombardi
Journal:  J Magn Reson Imaging       Date:  2009-07       Impact factor: 4.813

5.  Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death.

Authors:  Vincenzo Russo; Anna Rago; Bruno Pannone; Andrea A Papa; Federica Di Meo; Maria C Mayer; Anna Spasiano; Maria G Russo; Paolo Golino; Raffaele Calabrò; Gerardo Nigro
Journal:  Eur J Haematol       Date:  2011-04       Impact factor: 2.997

6.  Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance.

Authors:  P Nielsen; U Günther; M Dürken; R Fischer; J Düllmann
Journal:  J Lab Clin Med       Date:  2000-05

7.  Heart rate variability in beta-thalassemia patients.

Authors:  Wasarut Rutjanaprom; Natnicha Kanlop; Pimlak Charoenkwan; Rekwan Sittiwangkul; Somdet Srichairatanakool; Adisak Tantiworawit; Arintaya Phrommintikul; Siriporn Chattipakorn; Suthat Fucharoen; Nipon Chattipakorn
Journal:  Eur J Haematol       Date:  2009-07-06       Impact factor: 2.997

8.  Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major.

Authors:  A Pepe; V Positano; M Capra; A Maggio; C L Pinto; A Spasiano; G Forni; G Derchi; B Favilli; G Rossi; E Cracolici; M Midiri; M Lombardi
Journal:  Heart       Date:  2009-06-01       Impact factor: 5.994

9.  Deferasirox does not induce QT/QTc-prolongation in healthy subjects.

Authors:  R Sechaud; T Dumortier; S Balez
Journal:  Int J Clin Pharmacol Ther       Date:  2009-05       Impact factor: 1.366

10.  Nutritional deficiencies in iron overloaded patients with hemoglobinopathies.

Authors:  Susan Claster; John C Wood; Leila Noetzli; Susan M Carson; Thomas C Hofstra; Rachna Khanna; Thomas D Coates
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

View more
  20 in total

Review 1.  Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.

Authors:  Ljuba Bacharova; Martin Ugander
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

Review 2.  Electrocardiographic Presentation, Cardiac Arrhythmias, and Their Management in β-Thalassemia Major Patients.

Authors:  Vincenzo Russo; Anna Rago; Andrea Antonio Papa; Gerardo Nigro
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-06-20       Impact factor: 1.468

3.  The effect of metoprolol succinate on the cardiac function of patients with thalassaemia cardiomyopathy: a double-blind randomised study.

Authors:  Javad Kojury; Abdolali Zolghadrasli; Mehran Karimi; Mohammad Ali Babaee Beighi; Soha Namazi
Journal:  Heart Asia       Date:  2014-04-17

4.  Heart Rate Recovery as a Novel Test for Predicting Cardiac Involvement in Beta-Thalassemia Major.

Authors:  Selcuk Kucukseymen; Isa Oner Yuksel; Goksel Cagirci; Erkan Koklu; Volkan Karakus; Serkan Cay; Gorkem Kus; Erdal Kurtoglu; Sakir Arslan
Journal:  Acta Cardiol Sin       Date:  2017-07       Impact factor: 2.672

Review 5.  Cardiac complications in beta-thalassemia: From mice to men.

Authors:  Sirinart Kumfu; Suthat Fucharoen; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-09

Review 6.  Advancement of echocardiography for surveillance of iron overload cardiomyopathy: comparison to cardiac magnetic resonance imaging.

Authors:  M Jason Zimmerman; Douglas R Rosing; Yukitaka Shizukuda
Journal:  J Echocardiogr       Date:  2021-03-26

7.  The Role of Heart Rate Variability and Fragmented QRS for Determination of Subclinical Cardiac Involvement in Beta-Thalassemia Major.

Authors:  Mozhgan Parsaee; Amir Farjam Fazelifar; Elham Ansaripour; Azita Azarkeyvan; Behshid Ghadrdoost; Ashraf Charmizadeh; Mohaddeseh Behjati
Journal:  Pulse (Basel)       Date:  2020-02-11

8.  Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.

Authors:  Antonella Meloni; Jon Detterich; Vasili Berdoukas; Alessia Pepe; Massimo Lombardi; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2013-02-06       Impact factor: 10.047

9.  Pulmonary hypertension in well-transfused thalassemia major patients.

Authors:  Antonella Meloni; Jon Detterich; Alessia Pepe; Paul Harmatz; Tom D Coates; John C Wood
Journal:  Blood Cells Mol Dis       Date:  2014-11-24       Impact factor: 3.039

10.  Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study.

Authors:  Srikanth R Ambati; Rachel E Randolph; Kevin Mennitt; Dorothy A Kleinert; Jonathan W Weinsaft; Patricia J Giardina
Journal:  Am J Hematol       Date:  2013-06-28       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.